Clinical Trial: A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751367) titled 'A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery' on July 20.

Brief Summary: This study aims to investigate the efficacy and safety of high-dose Oryz-Aspergillus Enzyme And Pancreatin Tablet in treating postoperative pancreatic exocrine insufficiency (PEI), aiming to fill the gap in evidence-based medicine and promote standardized treatment.

Study Start Date: Sept. 18

Study Type: INTERVENTIONAL

Condition: Pancreatic Exocrine Insufficiency, Adul

Intervention: DRUG: High-dose group: Oryz-Aspergillus Enzyme and P...